243 related articles for article (PubMed ID: 12180893)
1. Recent advances in the treatment of AIDS-related Kaposi's sarcoma.
Cattelan AM; Trevenzoli M; Aversa SM
Am J Clin Dermatol; 2002; 3(7):451-62. PubMed ID: 12180893
[TBL] [Abstract][Full Text] [Related]
2. Treatments of AIDS-related Kaposi's sarcoma.
Aversa SM; Cattelan AM; Salvagno L; Crivellari G; Banna G; Trevenzoli M; Chiarion-Sileni V; Monfardini S
Crit Rev Oncol Hematol; 2005 Mar; 53(3):253-65. PubMed ID: 15718150
[TBL] [Abstract][Full Text] [Related]
3. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
Dezube BJ
Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
[TBL] [Abstract][Full Text] [Related]
4. Therapy for Kaposi's sarcoma: recent advances and experimental approaches.
Yarchoan R
J Acquir Immune Defic Syndr; 1999 Aug; 21 Suppl 1():S66-73. PubMed ID: 10430221
[TBL] [Abstract][Full Text] [Related]
5. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma.
McGarvey ME; Tulpule A; Cai J; Zheng T; Masood R; Espina B; Arora N; Smith DL; Gill PS
Curr Opin Oncol; 1998 Sep; 10(5):413-21. PubMed ID: 9800111
[TBL] [Abstract][Full Text] [Related]
6. Treatment of AIDS-related cutaneous Kaposi's sarcoma with topical alitretinoin (9-cis-retinoic acid) gel. Panretin Gel North American Study Group.
Walmsley S; Northfelt DW; Melosky B; Conant M; Friedman-Kien AE; Wagner B
J Acquir Immune Defic Syndr; 1999 Nov; 22(3):235-46. PubMed ID: 10770343
[TBL] [Abstract][Full Text] [Related]
7. AIDS-related Kaposi's sarcoma patients with visceral manifestations. Response to human chorionic gonadotropin preparations.
Hermans P; Clumeck N; Picard O; van Vooren JP; Duriez P; Zucman D; Bryant JL; Gill P; Lunardi-Iskandar Y; Gallo RC
J Hum Virol; 1998; 1(2):82-9. PubMed ID: 10195236
[TBL] [Abstract][Full Text] [Related]
8. New therapies for the treatment of AIDS-related Kaposi sarcoma.
Dezube BJ
Curr Opin Oncol; 2000 Sep; 12(5):445-9. PubMed ID: 10975552
[TBL] [Abstract][Full Text] [Related]
9. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
[TBL] [Abstract][Full Text] [Related]
10. AIDS-related Kaposi's sarcoma: current treatment options, future trends.
Mitsuyasu RT
Oncology (Williston Park); 2000 Jun; 14(6):867-78; discussion 878, 881-3, 887-. PubMed ID: 10887636
[TBL] [Abstract][Full Text] [Related]
11. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
[TBL] [Abstract][Full Text] [Related]
12. Novel pharmacological therapies for the treatment of AIDS-related Kaposi's sarcoma.
Cattelan AM; Trevenzoli M; Aversa SM
Expert Opin Investig Drugs; 2004 May; 13(5):501-13. PubMed ID: 15155125
[TBL] [Abstract][Full Text] [Related]
13. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment.
Dezube BJ; Pantanowitz L; Aboulafia DM
AIDS Read; 2004 May; 14(5):236-8, 243-4, 251-3. PubMed ID: 15199854
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Kaposi's sarcoma--an update.
Toschi E; Sgadari C; Monini P; Barillari G; Bacigalupo I; Palladino C; Baccarini S; Carlei D; Grosso G; Sirianni MC; Ensoli B
Anticancer Drugs; 2002 Nov; 13(10):977-87. PubMed ID: 12439331
[TBL] [Abstract][Full Text] [Related]
15. Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma.
Bodsworth NJ; Bloch M; Bower M; Donnell D; Yocum R;
Am J Clin Dermatol; 2001; 2(2):77-87. PubMed ID: 11705307
[TBL] [Abstract][Full Text] [Related]
16. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era.
La Ferla L; Pinzone MR; Nunnari G; Martellotta F; Lleshi A; Tirelli U; De Paoli P; Berretta M; Cacopardo B
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2354-65. PubMed ID: 24065230
[TBL] [Abstract][Full Text] [Related]
17. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
19. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries.
Bacha JM; El-Mallawany NK; Slone JS; Wilkinson JP; Mehta PS; Campbell LR
Int J STD AIDS; 2020 Jul; 31(8):724-734. PubMed ID: 32493141
[TBL] [Abstract][Full Text] [Related]
20. Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy.
Cattelan AM; Calabrò ML; De Rossi A; Aversa SM; Barbierato M; Trevenzoli M; Gasperini P; Zanchetta M; Cadrobbi P; Monfardini S; Chieco-Bianchi L
Int J Oncol; 2005 Sep; 27(3):779-85. PubMed ID: 16077928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
